Cardiac release of urocortin precedes the occurrence of irreversible myocardial damage in the rat heart exposed to ischemia/reperfusion injury

Richard A. Knight, Carol Chen-Scarabelli, Zhaokan Yuan, Roy B. McCauley, J. Di Rezze, Gabriele M. Scarabelli, Paul A. Townsend, David Latchman, Louis Saravolatz, Giuseppe Faggian, Alessandro Mazzucco, Hardial S. Chowdrey, Anastasis Stephanou, Tiziano M. Scarabelli

    Research output: Contribution to journalArticlepeer-review

    Abstract

    This study evaluates whether cardiac ischemia induces release of urocortin, before and independently from myocyte cell death. Urocortin levels rose after 5-min ischemia and peaked after 10-min ischemia, when cell death was not detected. However, myocyte apoptosis and/or necrosis occurred following 20- and 30-min ischemia, which paralleled a fall in urocortin levels, suggesting that urocortin expression and release are mainly sustained by metabolically challenged, though still viable myocytes. Hence, since cardiac release of urocortin, unlike that of conventional biomarkers, occurs before and apart from cell death, urocortin levels may be clinically useful in the diagnosis of sublethal myocardial ischemia. © 2008 Federation of European Biochemical Societies.
    Original languageEnglish
    Pages (from-to)984-990
    Number of pages6
    JournalFEBS Letters
    Volume582
    Issue number6
    DOIs
    Publication statusPublished - 19 Mar 2008

    Keywords

    • Apoptosis
    • Biomarker
    • Sublethal ischemia
    • Urocortin

    Fingerprint

    Dive into the research topics of 'Cardiac release of urocortin precedes the occurrence of irreversible myocardial damage in the rat heart exposed to ischemia/reperfusion injury'. Together they form a unique fingerprint.

    Cite this